DrugPatentWatch Database Preview
Patent: 10,272,142
» See Plans and Pricing
Summary for Patent: 10,272,142
| Title: | Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders |
| Abstract: | Compositions and methods useful for the treatment of neuromyelitis optica (NMO) or neuromyelitis optica spectrum disorder (NMOSD) are disclosed. |
| Inventor(s): | Broom; Colin (Devon, PA), Dayno; Jeffrey (Maple Glen, PA) |
| Assignee: | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) |
| Application Number: | 14/539,405 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,272,142
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | 2039-05-17 | RX | search | |
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 002 | 1997-11-26 | Start Trial | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | 2039-05-17 | RX | search | |
| Alexion Pharm | SOLIRIS | eculizumab | INJECTABLE; IV (INFUSION) | 125166 | 001 | 2007-03-16 | Start Trial | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | 2039-05-17 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | 2039-05-17 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | SHIRE VIROPHARMA INCORPORATED (Lexington, MA) | 2039-05-17 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,272,142
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 112016010837 | Start Trial |
| Canada | 2930544 | Start Trial |
| European Patent Office | 3068424 | Start Trial |
| Japan | 2016540746 | Start Trial |
| Japan | 2020002180 | Start Trial |
| United States of America | 2015132296 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
